26 new tobacco companies granted production licenses

Jul.22.2022

26 new tobacco companies granted production licenses

National tobacco authority issued license to 26 tobacco production companies on July 22nd.

On July 22nd, 26 tobacco production companies were granted licenses and were announced on the National Tobacco Monopoly Bureau website. The list of companies can be found in the table below.

The data was sourced from the National Tobacco Monopoly Bureau and compiled by 2FIRSTS.

#Africa #South Africa #Regulation #E-cigarette Companies #Product

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Glas, the FDA, and the Future of Flavored ENDS

Glas, the FDA, and the Future of Flavored ENDS

PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition

PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition

India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.

Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets

Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets

Vape Club report reveals 1.3 million illegal e-cigarettes seized in UK by 2025, worth £10 million on the streets.

Mar.12 by 2FIRSTS.ai

FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements

FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements

FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.

Feb.10 by 2FIRSTS.ai

Oklahoma prisons to sell vapes and nicotine pouches to inmates in bid to curb contraband and violence

Oklahoma prisons to sell vapes and nicotine pouches to inmates in bid to curb contraband and violence

Oklahoma Department of Corrections (DOC) will launch a program allowing inmates to buy sealed disposable nicotine vapes and packs of nicotine pouches through prison commissaries. Tobacco has been banned in Oklahoma prisons for 10 years, and cigarettes and cigars will remain prohibited.

VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval

VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval

Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.

Mar.13 by 2FIRSTS.ai

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.

Related Topics

News

Related Read

PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition

PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition

Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets

Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets

FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements

FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements

Oklahoma prisons to sell vapes and nicotine pouches to inmates in bid to curb contraband and violence

Oklahoma prisons to sell vapes and nicotine pouches to inmates in bid to curb contraband and violence

VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval

VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands